Quiescence Modulates Stem Cell Maintenance and Regenerative Capacity in the Aging Brain.


Journal

Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066

Informations de publication

Date de publication:
07 03 2019
Historique:
received: 21 08 2018
revised: 12 11 2018
accepted: 24 01 2019
pubmed: 5 3 2019
medline: 7 1 2020
entrez: 5 3 2019
Statut: ppublish

Résumé

The function of somatic stem cells declines with age. Understanding the molecular underpinnings of this decline is key to counteract age-related disease. Here, we report a dramatic drop in the neural stem cells (NSCs) number in the aging murine brain. We find that this smaller stem cell reservoir is protected from full depletion by an increase in quiescence that makes old NSCs more resistant to regenerate the injured brain. Once activated, however, young and old NSCs show similar proliferation and differentiation capacity. Single-cell transcriptomics of NSCs indicate that aging changes NSCs minimally. In the aging brain, niche-derived inflammatory signals and the Wnt antagonist sFRP5 induce quiescence. Indeed, intervention to neutralize them increases activation of old NSCs during homeostasis and following injury. Our study identifies quiescence as a key feature of old NSCs imposed by the niche and uncovers ways to activate NSCs to repair the aging brain.

Identifiants

pubmed: 30827680
pii: S0092-8674(19)30103-5
doi: 10.1016/j.cell.2019.01.040
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1407-1419.e14

Subventions

Organisme : Medical Research Council
ID : MR/N026063/1
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Georgios Kalamakis (G)

Molecular Neurobiology, German Cancer Research Center, 69120 Heidelberg, Germany; University of Heidelberg, 69120 Heidelberg, Germany.

Daniel Brüne (D)

Molecular Neurobiology, German Cancer Research Center, 69120 Heidelberg, Germany.

Srikanth Ravichandran (S)

Luxembourg Centre for Systems Biomedicine, University of Luxembourg, 4362, Luxembourg.

Jan Bolz (J)

Molecular Neurobiology, German Cancer Research Center, 69120 Heidelberg, Germany.

Wenqiang Fan (W)

Institute of Physiological Chemistry, University Medical Center Johannes Gutenberg University Mainz, 55128 Mainz, Germany; Focus Program Translational Neuroscience, Johannes Gutenberg University Mainz, 55131 Mainz, Germany.

Frederik Ziebell (F)

Molecular Neurobiology, German Cancer Research Center, 69120 Heidelberg, Germany; Institute of Applied Mathematics, Interdisciplinary Center for Scientific Computing and Bioquant, Heidelberg University, 69120 Heidelberg, Germany.

Thomas Stiehl (T)

Institute of Applied Mathematics, Interdisciplinary Center for Scientific Computing and Bioquant, Heidelberg University, 69120 Heidelberg, Germany.

Francisco Catalá-Martinez (F)

Molecular Neurobiology, German Cancer Research Center, 69120 Heidelberg, Germany.

Janina Kupke (J)

Molecular Neurobiology, German Cancer Research Center, 69120 Heidelberg, Germany.

Sheng Zhao (S)

Molecular Neurobiology, German Cancer Research Center, 69120 Heidelberg, Germany.

Enric Llorens-Bobadilla (E)

Molecular Neurobiology, German Cancer Research Center, 69120 Heidelberg, Germany.

Katharina Bauer (K)

Heidelberg Center for Personalized Oncology (DKFZ-HIPO), German Cancer Research Center, 69120 Heidelberg, Germany.

Stefanie Limpert (S)

Molecular Neurobiology, German Cancer Research Center, 69120 Heidelberg, Germany.

Birgit Berger (B)

Molecular Neurobiology, German Cancer Research Center, 69120 Heidelberg, Germany.

Urs Christen (U)

Goethe University Hospital Frankfurt/ZAFES, 60596 Frankfurt, Germany.

Peter Schmezer (P)

German Cancer Research Center, Division of Epigenomics and Cancer Risk Factors, 69120 Heidelberg, Germany.

Jan Philipp Mallm (JP)

Division Chromatin Networks, German Cancer Research Center, 69120 Heidelberg, Germany; Single-cell Open Lab, German Cancer Research Center, 69120 Heidelberg, Germany.

Benedikt Berninger (B)

Institute of Physiological Chemistry, University Medical Center Johannes Gutenberg University Mainz, 55128 Mainz, Germany; Focus Program Translational Neuroscience, Johannes Gutenberg University Mainz, 55131 Mainz, Germany; Institute of Psychiatry, Psychology & Neuroscience, Centre for Developmental Neurobiology, King's College London, London SE1 1UL, UK; Institute of Psychiatry, Psychology & Neuroscience, MRC Centre for Neurodevelopmental Disorders, King's College London, London SE1 1UL, UK.

Simon Anders (S)

Center for Molecular Biology, Heidelberg University, 69120 Heidelberg, Germany.

Antonio Del Sol (A)

Luxembourg Centre for Systems Biomedicine, University of Luxembourg, 4362, Luxembourg; CIC bioGUNE, 48160 Derio, Spain; IKERBASQUE, Basque Foundation for Science, 48009 Bilbao, Spain; Moscow Institute of Physics and Technology, 141700 Dolgoprudny, Russia.

Anna Marciniak-Czochra (A)

Institute of Applied Mathematics, Interdisciplinary Center for Scientific Computing and Bioquant, Heidelberg University, 69120 Heidelberg, Germany.

Ana Martin-Villalba (A)

Molecular Neurobiology, German Cancer Research Center, 69120 Heidelberg, Germany. Electronic address: a.martin-villalba@dkfz-heidelberg.de.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH